Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age
Clinical trial NCT06048913 · COMPLETED
Trial details
- NCT number
- NCT06048913
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-01
- Primary completion
- 2025-01-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.